A partner with Childers, Schlueter & Smith, LLC,, Brandon Smith has devoted his practice to pharmaceutical litigation, mass torts, products liability and serious personal injury. A frequent guest spea
FDA & Prescription Drugs
Every time you turn on the television, you are most likely bombarded by a barrage of advertisements for prescription drugs. While you might be wary of marketer’s claims and promises as to their effect, you can at least rest assured that all have passed stringent…
@large.jpg)
FDA & Prescription Drugs
In 2014, A young woman in Snellville, Georgia visited her doctor with claims of depression. Her physician prescribed lamotrigine, also marketed under the tradename Lamictal, a mood-stabilizing anticonvulsant best known for controlling seizures with those who suffer from epilepsy. While the medicatio
FDA & Prescription Drugs
In the third consecutive talcum powder trial, a St. Louis City jury award plaintiff Deborah Giannecchini $2.57 million in compensatory damages and 67.5 million in punitive damages against Johnson & Johnson and the Imerys Talc America defendants for their talc-containing personal hygiene product. Per
Legal
The FDA just released more information on Invokana and Farxiga related to acute kidney failure. A topic and drug Childers, Schlueter & Smith have been investigating for a long time now. Check out our: Top 10 Things Invokana Patients Need To Know… As…
Uncategorized
Nexium, Prilosec and Prevacid, commonly used to treat heartburn, indigestion, gastritis and/or acid reflux, have recently been linked to kidney disease and complications in two major independent medical studies. In one January 2016 medical study by the Journal of American Medical Association involvi
FDA & Prescription Drugs
An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at the Ontario Superior Court of Justice, seeks class-action status, which is expected to be determined within the next six or…
FDA & Prescription Drugs
The diabetes drug Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly. In May 2015, the Institute for Safe Medication Practices released…
Medical Devices & Implants
Although federal law requires the reporting of adverse events, no reports concerning power morcellators had been received by the U.S. Food and Drug Administration (FDA) prior to December 2013, according to The Cancer Letter. Prior to December 2013, the FDA had received no Medical Device…
FDA & Prescription Drugs
According to a case management order issued by U.S. District Judge Eldon Fallon, 40 cases will be chosen for the Xarelto bellwether pool, with each side selecting 10 cases and an additional 20 chosen randomly. According to Judge Fallon’s plan: Half of the cases will…
Medical Devices & Implants
A medical study published in the October 2015 issue of the Annals of Surgery takes a closer look at whether trauma patients actually benefit from having inferior vena cava (IVC) filters implanted, or instead face a greater risk of life-threatening complications associated with the filters…
Legal
Electronic cigarettes (e-cigarettes) have only been around since 2004, too little time for researchers to complete definitive studies on their effects on human health, but Americans polled by STAT and the Harvard T.H. Chan School of Public Health believe that the devices are harmful. This…
FDA & Prescription Drugs
Janssen Pharmaceuticals and its parent company, Johnson & Johnson, recently entered into a settlement agreement with the Commonwealth of Kentucky over allegations surrounding the drug Risperdal. Janssen agreed to: Pay $15.5 million to the state of Kentucky Fully disclose the associated risks of Ris